Bausch Health Companies's latest marketcap:
As of 07/05/2025, Bausch Health Companies's market capitalization has reached $2.61 B. According to our data, Bausch Health Companies is the 5251th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 2.61 B |
| Revenue (ttm) | 9.73 B |
| Net Income (ttm) | -40,000,000 |
| Shares Out | 369.55 M |
| EPS (ttm) | -0.11 |
| Forward PE | 1.70 |
| Ex-Dividend Date | n/a |
| Earnings Date | 07/30/2025 |
Bausch Health Companies's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | $2.61 B | -11.24% | 5251 |
| 12/31/2024 | $2.96 B | 1.22% | 4402 |
| 12/29/2023 | $2.93 B | 28.88% | 4353 |
| 12/30/2022 | $2.27 B | -77.09% | 4928 |
| 12/31/2021 | $9.92 B | 34.3% | 1815 |
| 12/31/2020 | $7.39 B | -29.94% | 2079 |
| 12/31/2019 | $10.54 B | 63.22% | 1274 |
| 12/31/2018 | $6.46 B | -10.81% | 1651 |
| 12/29/2017 | $7.24 B | 43.49% | 1749 |
| 12/30/2016 | $5.05 B | -85.53% | 1922 |
Company Profile
Bausch Health Companies Inc. Overview
Bausch Health Companies Inc. is a diversified specialty pharmaceutical and medical device company that develops, manufactures, and markets a wide range of products across multiple therapeutic areas. The company operates globally, with a focus on gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.
Business Segments
- Salix: Specializes in gastroenterology products.
- International: Markets aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products.
- Solta Medical: Focuses on the sale of aesthetic medical devices.
- Diversified: Offers pharmaceutical products in neurology, dermatology, generic pharmaceuticals, and dentistry.
- Bausch + Lomb: Provides vision care, surgical, and ophthalmic pharmaceutical products.
Corporate Background
Formerly known as Valeant Pharmaceuticals International, Inc., the company rebranded as Bausch Health Companies Inc. in July 2018. It is headquartered in Laval, Canada.
Frequently Asked Questions
-
What is Bausch Health Companies's (BHC) current market cap?As of 07/05/2025, Bausch Health Companies (including the parent company, if applicable) has an estimated market capitalization of $2.61 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Bausch Health Companies (BHC) rank globally by market cap?Bausch Health Companies global market capitalization ranking is approximately 5251 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.